Gastrointestinal stromal tumor mesenchymal neoplasms: the offspring that choose the wrong path

about

Association of high expression of Groβ with clinical and pathological characteristics of unfavorable prognosis in gastrointestinal stromal tumors.Suicide Gene Therapy for Cancer - Current Strategies.

P2860

Q35511907-EB970F56-693F-485B-8669-7F4FF75A97AA Q37347017-5E7B5495-BF47-46DA-8AFE-B9C96022D963

P2860

Gastrointestinal stromal tumor mesenchymal neoplasms: the offspring that choose the wrong path

Item

http://www.wikidata.org/entity/Q36753291

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Gastrointestinal stromal tumor ...... ing that choose the wrong path

@en

type

Item

label

Gastrointestinal stromal tumor ...... ing that choose the wrong path

@en

prefLabel

Gastrointestinal stromal tumor ...... ing that choose the wrong path

@en

P1476

Gastrointestinal stromal tumor ...... ing that choose the wrong path

@en

P2093

Aikaterini Stylianaki

http://www.w3.org/2001/XMLSchema#string

Ioanna Kougioumtzi

http://www.w3.org/2001/XMLSchema#string

Nikolaos Katsikogiannis

http://www.w3.org/2001/XMLSchema#string

Nikolaos Machairiotis

http://www.w3.org/2001/XMLSchema#string

Paul Zarogoulidis

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular correlates of imatinib resistance in gastrointestinal stromal tumors.

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor.

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial.

Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group.

Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial.

Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up.

Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033.

Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal.

P304

127-131

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/JMDH.S43703

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Konstantinos E Tsimogiannis

P577

2013-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23579364

http://www.w3.org/2001/XMLSchema#string

P932

3621649

http://www.w3.org/2001/XMLSchema#string

Gastrointestinal stromal tumor mesenchymal neoplasms: the offspring that choose the wrong path

about

P2860

P2860

Gastrointestinal stromal tumor mesenchymal neoplasms: the offspring that choose the wrong path

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932